{"url_path":"/sec/pbm/10-k/2026/item-18","section_key":"item-18","section_title":"Item 18 FINANCIAL STATEMENTS","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","accession_number":"0001213900-26-070607","cik":"0001985062","ticker":"PBM","issuer_name":"PSYENCE BIOMEDICAL LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","primary_entity_key":"0001985062","primary_entity_name":"PSYENCE BIOMEDICAL LTD."},"word_count":31,"has_tables":true,"body_markdown":"** **\n\nITEM 18. FINANCIAL STATEMENTS\n\n \n\nFinancial Statements Filed as Part of this Annual\nReport:\n\n \n\nAudited consolidated financial statements for\nthe years ended March 31, 2026, March 31, 2025 and March 31, 2024."}